MedTrace Logo

Placebo-Controlled Multi-Centre Double-Blind Trial for Adults With Extended-Release Methylphenidate for ADHD

NCT00619840 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 363

Last updated 2008-02-21

No results posted yet for this study

Summary

Investigation of efficacy and tolerability of extended-release MPD in adults with ADHD, compared with a placebo, and to acquire knowledge through long-term observation of adults

Conditions

  • Attention Deficit Hyperactivity Disorder

Interventions

DRUG

methylphenidate hydrochloride

sustained release, 10 mg capsule 1-3 capsules twice daily according to an individual titration schedule

DRUG

Placebo

10 mg capsule 1-3 capsules twice daily according to an individual titration schedule

Sponsors & Collaborators

  • Medice Arzneimittel Pütter GmbH & Co KG

    lead INDUSTRY

Principal Investigators

  • Michael Rösler, Prof. Dr. · Institute of Forensic Psychology and Psychiatry, University of Saarland

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-11-30
Primary Completion
2006-05-31

Countries

  • Germany

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00619840 on ClinicalTrials.gov